These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1871718)

  • 21. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood in vitro.
    Edwards CM; Heptinstall S; Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):441-7. PubMed ID: 9844710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of rabbit platelet aggregation by nucleoside 5'-alkylphosphates: correlation with inhibition of agonist-induced calcium influx.
    Sugatani J; Iwai T; Watanabe M; Machida K; Tanaka T; Maeda T; Miwa M
    Biochem Pharmacol; 2000 Jul; 60(2):197-205. PubMed ID: 10825464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological effect of nitroprusside on platelet aggregation.
    Parrish PR; Larson DF
    J Extra Corpor Technol; 1999 Dec; 31(4):162-8. PubMed ID: 10915472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A plasma inhibitor of ristocetin-induced platelet aggregation in patients with sickle hemoglobinopathies.
    Leichtman DA; Brewer GJ
    Am J Hematol; 1977; 2(3):251-8. PubMed ID: 596369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of human platelet function by sulfatides.
    Devaiah AK; Raife TJ; Barton JA; Olson JD
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):543-50. PubMed ID: 10997794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phorbol-myristate-acetate-induced platelet aggregation in the presence of inhibitors.
    Jerushalmy Z; Englender T; Shaklai M
    Acta Haematol; 1988; 80(4):210-5. PubMed ID: 3146199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial differences in ristocetin-induced platelet aggregation.
    Buchanan GR; Holtkamp CA; Levy EN
    Br J Haematol; 1981 Nov; 49(3):455-64. PubMed ID: 6975118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of hexahydrocurcumin on human platelet aggregation.
    Dong HP; Yang RC; Chunag IC; Huang LJ; Li HT; Chen HL; Chen CY
    Nat Prod Commun; 2012 Jul; 7(7):883-4. PubMed ID: 22908571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Inhibition of ristocetin-induced platelet aggregation (RIPA) by Haemaccel and fibrinogen.
    Stibbe J; Kirby E
    Thromb Diath Haemorrh; 1975 Nov; 34(2):583. PubMed ID: 1198487
    [No Abstract]   [Full Text] [Related]  

  • 33. The antiplatelet aggregatory activity of Acacia nilotica is due to blockade of calcium influx through membrane calcium channels.
    Shah BH; Safdar B; Virani SS; Nawaz Z; Saeed SA; Gilani AH
    Gen Pharmacol; 1997 Aug; 29(2):251-5. PubMed ID: 9251908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism(s) of the antiaggregatory effects of cryptolepine: the role of cyclic adenosine monophosphate and cellular Ca2+.
    Oyekan AO; Ablordeppey SY
    Gen Pharmacol; 1993 Mar; 24(2):461-9. PubMed ID: 7683302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the observation of a synergistic response in platelet aggregation induced by pairs of excitatory agonists.
    Petty AC; Scrutton MC
    Platelets; 1993; 4(3):159-66. PubMed ID: 21043862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical and functional characterization of recombinant Rhodnius prolixus platelet aggregation inhibitor 1 as a novel lipocalin with high affinity for adenosine diphosphate and other adenine nucleotides.
    Francischetti IM; Andersen JF; Ribeiro JM
    Biochemistry; 2002 Mar; 41(11):3810-8. PubMed ID: 11888300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further characterization of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients.
    Nugent DF; Dinan TG; Leonard BE
    J Affect Disord; 1995 Apr; 33(4):227-31. PubMed ID: 7790676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gelatin-based resuscitation fluids on platelet aggregation.
    Evans PA; Glenn JR; Heptinstall S; Madira W
    Br J Anaesth; 1998 Aug; 81(2):198-202. PubMed ID: 9813523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Inhibition of bovine factor VIII and ristocetin plus human factor VIII induced platelet agglutination by small peptides.
    Macfarlane DE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582-3. PubMed ID: 1239092
    [No Abstract]   [Full Text] [Related]  

  • 40. A new hypoglycemic agent, midaglizole, blunts diabetic platelet aggregation: a possible role of alpha 2 blockade.
    Inaba M; Katayama S; Kawazu S; Suzuki M; Negishi K; Ishii J
    Diabetes Res Clin Pract; 1989 Sep; 7(3):235-41. PubMed ID: 2575025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.